tiprankstipranks
Trending News
More News >
CBD Life Sciences (CBDL)
OTHER OTC:CBDL
US Market

CBD Life Sciences (CBDL) Ratios

Compare
133 Followers

CBD Life Sciences Ratios

CBDL's free cash flow for Q1 2025 was $-0.78. For the 2025 fiscal year, CBDL's free cash flow was decreased by $ and operating cash flow was $-2.35. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
15.12 15.12 17.18 8.06 0.00
Quick Ratio
14.21 14.21 14.93 7.21 0.00
Cash Ratio
8.61 8.61 0.46 0.10 0.00
Solvency Ratio
-15.75 -1.27 -49.65 -0.93 0.00
Operating Cash Flow Ratio
-5.50 -3.61 -41.26 -0.67 0.00
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 543.85K$ 543.85K$ 228.69K$ 174.58K$ 178.01K
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.05 1.05 1.04 1.06 1.00
Debt Service Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.50 3.26 <0.01 0.11 <0.01
Profitability Margins
Gross Profit Margin
-9.89%42.20%-9.08%-18.31%-174.90%
EBIT Margin
-987.66%-103.44%-695.36%-47.01%-536.57%
EBITDA Margin
-935.53%-103.44%-644.34%-13.77%-503.15%
Operating Profit Margin
-987.66%-103.44%-695.36%-47.01%-536.57%
Pretax Profit Margin
-905.52%-49.76%-695.36%-47.01%-536.57%
Net Profit Margin
-905.52%-49.76%-695.36%-47.01%-536.57%
Continuous Operations Profit Margin
-905.52%-49.76%-695.36%-47.01%-536.57%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
91.68%48.11%100.00%100.00%100.00%
Return on Assets (ROA)
-79.89%-6.08%-186.16%-18.74%-181.72%
Return on Equity (ROE)
-131.48%-6.38%-192.86%-19.91%-181.72%
Return on Capital Employed (ROCE)
-91.52%-13.26%-192.86%-19.91%-181.72%
Return on Invested Capital (ROIC)
-91.52%-13.26%-192.86%-19.91%-181.72%
Return on Tangible Assets
-91.22%-6.94%-254.74%-26.82%-230.41%
Earnings Yield
-104.35%-5.95%-48.89%-0.02%>-0.01%
Efficiency Ratios
Receivables Turnover
0.33 0.46 0.00 0.00 0.00
Payables Turnover
2.34 1.70 0.00 0.00 0.00
Inventory Turnover
2.23 1.62 3.73 9.50 54.25
Fixed Asset Turnover
0.00 0.00 3.45 1.88 0.84
Asset Turnover
0.09 0.12 0.27 0.40 0.34
Working Capital Turnover Ratio
0.17 0.25 0.54 0.95 0.26
Cash Conversion Cycle
1.12K 811.50 97.73 38.44 6.73
Days of Sales Outstanding
1.11K 800.69 0.00 0.00 0.00
Days of Inventory Outstanding
163.99 225.26 97.73 38.44 6.73
Days of Payables Outstanding
156.12 214.46 0.00 0.00 0.00
Operating Cycle
1.27K 1.03K 97.73 38.44 6.73
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
>-0.01 >-0.01 >-0.01 <0.01 >-0.01
CapEx Per Share
<0.01 0.00 <0.01 0.00 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 -0.12 1.07
Dividend Paid and CapEx Coverage Ratio
-10.00T> 0.00 -194.36K 0.00 -13.87
Capital Expenditure Coverage Ratio
-10.00T> 0.00 -194.36K 0.00 -13.87
Operating Cash Flow Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
-2.98 -1.42 -5.35 -0.10 -5.97
Free Cash Flow Yield
-75.28%-16.93%-37.65%<0.01%>-0.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.96 -16.80 -2.05 -5.18K -47.34K
Price-to-Sales (P/S) Ratio
3.96 8.36 14.22 2.44K 254.03K
Price-to-Book (P/B) Ratio
0.80 1.07 3.94 1.03K 86.03K
Price-to-Free Cash Flow (P/FCF) Ratio
-1.33 -5.91 -2.66 207.90K -39.66K
Price-to-Operating Cash Flow Ratio
-2.91 -5.91 -2.66 -24.46K -42.52K
Price-to-Earnings Growth (PEG) Ratio
>-0.01 0.17 0.03 -25.90 946.87
Price-to-Fair Value
0.80 1.07 3.94 1.03K 86.03K
Enterprise Value Multiple
0.08 -4.82 -2.20 -17.69K -50.49K
Enterprise Value
-50.05K 490.40K 1.54M 407.06M 40.71B
EV to EBITDA
0.08 -4.82 -2.20 -17.69K -50.49K
EV to Sales
-0.70 4.99 14.16 2.44K 254.03K
EV to Free Cash Flow
0.24 -3.52 -2.64 207.90K -39.66K
EV to Operating Cash Flow
0.24 -3.52 -2.64 -24.46K -42.52K
Tangible Book Value Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Shareholders’ Equity Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.00
Revenue Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
0.92 0.48 1.00 1.00 1.00
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.18 1.04
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.64 2.84 0.77 0.21 1.11
Currency in USD